Sign in

Filippo Peter Caldini [document 0]

Interim Chief Executive Officer at ESTABLISHMENT LABS HOLDINGS
Since March 1, 2025
Age
60 years
Education
Holds a BA in Political Science from Boston University, an MBA from Northeastern University, and a Master’s in International Economics and Management from Bocconi University.
Tenure
Joined as President on 08-20-2024 before being promoted to Interim Chief Executive Officer on 03-01-2025.

Also at ESTABLISHMENT LABS HOLDINGS

RSD[0
Rajbir S. Denhoy [document 0]
Chief Financial Officer
SRM[0
S. Ross Mansbach [document 0]
General Counsel and Chief Compliance Officer

About

Filippo "Peter" Caldini is a seasoned executive currently serving as the Interim Chief Executive Officer at ESTA, with a solid foundation in both education and industry experience.

He earned his BA in Political Science from Boston University, his MBA from Northeastern University, and a Master’s in International Economics and Management from Bocconi University, underscoring his strong academic background.

Prior to his role at ESTA, he held key leadership positions, including CEO roles at Acreage Holdings, Inc. and Bespoke Capital Acquisition Corp, as well as several executive positions at Pfizer Consumer Healthcare and Bayer AG, which provided him with significant industry expertise.

He joined ESTA as President on August 20, 2024, and was promoted to Interim Chief Executive Officer on March 1, 2025, tasked with steering the organization through strategic transitions and innovation.

$ESTA Performance Under Filippo Peter Caldini [document 0]

Past Roles

OrganizationRoleDate RangeDetails
Establishment Labs Holdings Inc. (ESTA) President Aug 2024 - Feb 2025 Preceded his appointment as Interim CEO
Acreage Holdings, Inc. Chief Executive Officer Dec 2020 - Jun 2023 N/A
Bespoke Capital Acquisition Corp. Chief Executive Officer and Director Jun 2019 - Dec 2020 N/A
Pfizer Consumer Healthcare Regional President North America 2017 - 2019 N/A
Pfizer Consumer Healthcare Regional President EMEA 2016 - 2017 N/A
Pfizer Consumer Healthcare Leader, Northern European Cluster 2015 - 2016 N/A
Bayer AG Head of Emerging Markets EMEA, General Manager of Bayer Consumer Care China, Head of the Nutritionals Strategic Business Unit 2009 - 2014 N/A
Wyeth Consumer Healthcare Various Commercial Roles 2002 - 2009 Held roles of increasing responsibility in the commercial area

Fixed Compensation

Data from  FY 2024
Component Name Amount Payment Schedule Additional Details
Salary$151,994 Annual (earned in 2024) Base salary for 2024
Stock Awards$399,977 Vests in 4 equal annual installments Restricted stock unit awards
Option Awards$598,672 Vests in 4 equal annual installments Stock option awards
All Other Compensation$16,449 As incurred during 2024 Breakdown: Life Insurance Premiums $654; Health Insurance Premiums $13,634; Other $2,161

Performance Compensation

Data from  FY 2024

Performance Compensation

Attribute Value Additional Details
Target Bonus Opportunity ($USD)$78,850 Pro-rated based on start date in August 2024
Bonus Earned ($USD)$60,408 Based on performance metrics for 2024
Overall Performance MetricsCorporate: 80%; Individual: 20% Corporate factor achieved at 65% for 2024
Corporate Performance BreakdownRevenue Targets: 35%; OPEX Targets: 25%; Year-End Cash Balance: 25%; Other Strategic Objectives: 15% Metrics weighted accordingly
ThresholdNone No minimum requirement set
MaximumNone No cap on bonus
Grant DateAugust 20, 2024 Applicable for the cash-based incentive plan
Vesting ScheduleN/A Not applicable as plan is cash-based
Evaluation Period2024 Performance measured over the 2024 period